| Target Price | $13.77 |
| Price | $10.04 |
| Potential |
37.15%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Emergent Biosolutions Inc 2026 .
The average Emergent Biosolutions Inc target price is $13.77.
This is
37.15%
register free of charge
$15.75
56.87%
register free of charge
$12.12
20.72%
register free of charge
|
|
| A rating was issued by 7 analysts: 5 Analysts recommend Emergent Biosolutions Inc to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Emergent Biosolutions Inc stock has an average upside potential 2026 of
37.15%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 1,043.60 | 815.98 |
| 0.54% | 21.81% | |
| EBITDA Margin | -1.57% | 22.99% |
| 87.87% | 1,562.95% | |
| Net Margin | -18.26% | 13.37% |
| 74.80% | 173.21% |
4 Analysts have issued a sales forecast Emergent Biosolutions Inc 2025 . The average Emergent Biosolutions Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Emergent Biosolutions Inc EBITDA forecast 2025. The average Emergent Biosolutions Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Emergent Biosolutions Inc Analysts have issued a net profit forecast 2025. The average Emergent Biosolutions Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.60 | 2.07 |
| 75.76% | 157.50% | |
| P/E | 4.85 | |
| EV/Sales | 1.16 |
4 Analysts have issued a Emergent Biosolutions Inc forecast for earnings per share. The average Emergent Biosolutions Inc EPS is
This results in the following potential growth metrics and future valuations:
Emergent Biosolutions Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 03 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 01 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 04 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 21 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 30 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 03 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 01 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 04 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 21 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 10 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 30 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


